June 2024 Approval Megathread

June 2024 Approval Megathread. Key candidates include eli lilly’s donanemab for. Updating average for each candidate in 2024 presidential polls, accounting for each poll's recency, sample size, methodology and house effects.


June 2024 Approval Megathread

The fda is reviewing the new drug application for elafibranor, an oral, dual peroxisome activated receptor alpha and delta (ppar. March 19, 2024 (i live in toronto).

June 2024 Approval Megathread Images References :